Literature DB >> 24900624

Exploring the chemical space of multitarget ligands using aligned self-organizing maps.

Janosch Achenbach1, Franca-Maria Klingler1, René Blöcher1, Daniel Moser1, Ann-Kathrin Häfner1, Carmen B Rödl1, Simon Kretschmer1, Björn Krüger2, Frank Löhr3, Holger Stark1, Bettina Hofmann1, Dieter Steinhilber1, Ewgenij Proschak1.   

Abstract

Design of multitarget drugs and polypharmacological compounds has become popular during the past decade. However, the main approach to design such compounds is to link two selective ligands via a flexible linker. Although such chimeric ligands often have reasonable potency in vitro, the in vivo efficacy is low due to high molecular weight, low ligand efficiency, and poor pharmacokinetic profile. We developed an unprecedented in silico approach for fragment-based design of multitarget ligands. It relies on superposition of the chemical spaces related to the affinity on single targets represented by self-organizing maps. We used this approach for screening of molecular fragments, which bind to the enzymes 5-lipoxygenase (5-LO) and soluble epoxide hydrolase (sEH). Using STD-NMR and activity-based assays, we were able to identify fragments binding to both targets. Furthermore, we were able to expand one of the fragments to a potent dual inhibitor bearing a reasonable molecular weight (MW = 446) and high affinity to both targets (IC50 of 0.03 μM toward 5-LO and 0.17 μM toward sEH).

Entities:  

Keywords:  5-lipoxygenase; Aligned self-organizing maps; soluble epoxide hydrolase; structure−activity relationships

Year:  2013        PMID: 24900624      PMCID: PMC4027374          DOI: 10.1021/ml4002562

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  24 in total

1.  A 'rule of three' for fragment-based lead discovery?

Authors:  Miles Congreve; Robin Carr; Chris Murray; Harren Jhoti
Journal:  Drug Discov Today       Date:  2003-10-01       Impact factor: 7.851

Review 2.  Designed multiple ligands. An emerging drug discovery paradigm.

Authors:  Richard Morphy; Zoran Rankovic
Journal:  J Med Chem       Date:  2005-10-20       Impact factor: 7.446

Review 3.  Multi-target therapeutics: when the whole is greater than the sum of the parts.

Authors:  Grant R Zimmermann; Joseph Lehár; Curtis T Keith
Journal:  Drug Discov Today       Date:  2006-11-28       Impact factor: 7.851

Review 4.  Recent developments and applications of saturation transfer difference nuclear magnetic resonance (STD NMR) spectroscopy.

Authors:  Jane L Wagstaff; Samantha L Taylor; Mark J Howard
Journal:  Mol Biosyst       Date:  2013-04-05

5.  Synthesis and structure-activity relationship studies of novel dual inhibitors of soluble epoxide hydrolase and 5-lipoxygenase.

Authors:  Karin Meirer; Carmen B Rödl; Joanna M Wisniewska; Sven George; Ann-Kathrin Häfner; Estel-la Buscató; Franca-Maria Klingler; Steffen Hahn; Dirk Berressem; Sandra K Wittmann; Dieter Steinhilber; Bettina Hofmann; Ewgenij Proschak
Journal:  J Med Chem       Date:  2013-02-07       Impact factor: 7.446

6.  Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor.

Authors:  M Mayer; B Meyer
Journal:  J Am Chem Soc       Date:  2001-06-27       Impact factor: 15.419

Review 7.  Rationally designed multitarget agents against inflammation and pain.

Authors:  S H Hwang; A T Wecksler; K Wagner; B D Hammock
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

Review 8.  Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases.

Authors:  John D Imig; Bruce D Hammock
Journal:  Nat Rev Drug Discov       Date:  2009-10       Impact factor: 84.694

9.  Automated design of ligands to polypharmacological profiles.

Authors:  Jérémy Besnard; Gian Filippo Ruda; Vincent Setola; Keren Abecassis; Ramona M Rodriguiz; Xi-Ping Huang; Suzanne Norval; Maria F Sassano; Antony I Shin; Lauren A Webster; Frederick R C Simeons; Laste Stojanovski; Annik Prat; Nabil G Seidah; Daniel B Constam; G Richard Bickerton; Kevin D Read; William C Wetsel; Ian H Gilbert; Bryan L Roth; Andrew L Hopkins
Journal:  Nature       Date:  2012-12-13       Impact factor: 49.962

10.  DrugBank 3.0: a comprehensive resource for 'omics' research on drugs.

Authors:  Craig Knox; Vivian Law; Timothy Jewison; Philip Liu; Son Ly; Alex Frolkis; Allison Pon; Kelly Banco; Christine Mak; Vanessa Neveu; Yannick Djoumbou; Roman Eisner; An Chi Guo; David S Wishart
Journal:  Nucleic Acids Res       Date:  2010-11-08       Impact factor: 16.971

View more
  12 in total

1.  Computer-Aided Fragment Growing Strategies to Design Dual Inhibitors of Soluble Epoxide Hydrolase and LTA4 Hydrolase.

Authors:  Lena Hefke; Kerstin Hiesinger; W Felix Zhu; Jan S Kramer; Ewgenij Proschak
Journal:  ACS Med Chem Lett       Date:  2020-04-08       Impact factor: 4.345

2.  Epoxy Fatty Acids: From Salt Regulation to Kidney and Cardiovascular Therapeutics: 2019 Lewis K. Dahl Memorial Lecture.

Authors:  John D Imig; Wojciech K Jankiewicz; Abdul H Khan
Journal:  Hypertension       Date:  2020-06-01       Impact factor: 10.190

Review 3.  Computational polypharmacology: a new paradigm for drug discovery.

Authors:  Rajan Chaudhari; Zhi Tan; Beibei Huang; Shuxing Zhang
Journal:  Expert Opin Drug Discov       Date:  2017-01-23       Impact factor: 6.098

4.  Late-Stage C-H Coupling Enables Rapid Identification of HDAC Inhibitors: Synthesis and Evaluation of NCH-31 Analogues.

Authors:  Hiromi Sekizawa; Kazuma Amaike; Yukihiro Itoh; Takayoshi Suzuki; Kenichiro Itami; Junichiro Yamaguchi
Journal:  ACS Med Chem Lett       Date:  2014-03-03       Impact factor: 4.345

5.  An in silico pipeline for the discovery of multitarget ligands: A case study for epi-polypharmacology based on DNMT1/HDAC2 inhibition.

Authors:  Fernando D Prieto-Martínez; Eli Fernández-de Gortari; José L Medina-Franco; L Michel Espinoza-Fonseca
Journal:  Artif Intell Life Sci       Date:  2021-09-12

Review 6.  Development of multitarget agents possessing soluble epoxide hydrolase inhibitory activity.

Authors:  Kerstin Hiesinger; Karen M Wagner; Bruce D Hammock; Ewgenij Proschak; Sung Hee Hwang
Journal:  Prostaglandins Other Lipid Mediat       Date:  2018-12-26       Impact factor: 3.072

7.  In silico polypharmacology: retrospective recognition vs. rational design.

Authors:  Ewgenij Proschak
Journal:  J Cheminform       Date:  2014-03-11       Impact factor: 5.514

8.  Design, Synthesis and Cellular Characterization of a Dual Inhibitor of 5-Lipoxygenase and Soluble Epoxide Hydrolase.

Authors:  Karin Meirer; Daniel Glatzel; Simon Kretschmer; Sandra K Wittmann; Markus Hartmann; René Blöcher; Carlo Angioni; Gerd Geisslinger; Dieter Steinhilber; Bettina Hofmann; Robert Fürst; Ewgenij Proschak
Journal:  Molecules       Date:  2016-12-29       Impact factor: 4.411

9.  Systematic Assessment of Fragment Identification for Multitarget Drug Design.

Authors:  Steffen Brunst; Jan S Kramer; Whitney Kilu; Jan Heering; Julius Pollinger; Kerstin Hiesinger; Sven George; Dieter Steinhilber; Daniel Merk; Ewgenij Proschak
Journal:  ChemMedChem       Date:  2021-02-04       Impact factor: 3.466

Review 10.  Discovery of Soluble Epoxide Hydrolase Inhibitors from Chemical Synthesis and Natural Products.

Authors:  Cheng-Peng Sun; Xin-Yue Zhang; Christophe Morisseau; Sung Hee Hwang; Zhan-Jun Zhang; Bruce D Hammock; Xiao-Chi Ma
Journal:  J Med Chem       Date:  2020-12-28       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.